Pfizer's Dividend Yield and Financial Health Under Scrutiny

A recent analysis of Pfizer noted that despite recent losses attributed to writedowns and non-cash expenses, the company maintains a 6.2% dividend yield. The company generated $11 billion in free cash flow over the past four quarters, which is more than $1 billion above its dividend payments during that time. Adjusted per-share earnings in the most recent quarter were $0.77, exceeding the quarterly dividend rate of $0.43.

The report suggests that Pfizer's underlying earnings and cash flow metrics indicate that its high dividend yield may not be as risky as some investors fear. This information relates directly to the company's financial stability and investment appeal.